We are live on ! Find out more
VMD icon

Viemed Healthcare

65 hedge funds and large institutions have $110M invested in Viemed Healthcare in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 23 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

23,800% more call options, than puts

Call options by funds: $239K | Put options by funds: $1K

5% more capital invested

Capital invested by funds: $104M → $110M (+$5.72M)

1.71% less ownership

Funds ownership: 49.59%47.88% (-1.7%)

13% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 23

14% less funds holding

Funds holding: 7665 (-11)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

58% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 19

Holders
65
Holders Change
-11
Holders Change %
-14.47%
% of All Funds
1.12%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
8
Increased
20
Reduced
23
Closed
19
Calls
$239K
Puts
$1K
Net Calls
+$238K
Net Calls Change
+$239K
Name Holding Trade Value Shares
Change
Change in
Stake
Connor, Clark & Lunn Investment Management (CC&L)
26
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$851K +$198K +30,900 +28%
Marshall Wace
27
Marshall Wace
United Kingdom
$844K -$36.1K -5,631 -4%
SRCM
28
Sage Rock Capital Management
New York
$705K -$245K -38,200 -25%
EI
29
EAM Investors
California
$671K +$713K +111,031 New
Two Sigma Investments
30
Two Sigma Investments
New York
$654K +$511K +79,614 +272%
Citadel Advisors
31
Citadel Advisors
Florida
$551K -$617K -96,178 -51%
VCP
32
Verus Capital Partners
Arizona
$528K +$428K +66,729 +314%
RC
33
RBF Capital
California
$480K
OAM
34
Oppenheimer Asset Management
New York
$467K -$56K -8,725 -10%
AA
35
Ancora Advisors
Ohio
$457K -$396K -61,729 -45%
TWC
36
TD Waterhouse Canada
Ontario, Canada
$386K +$278K +43,281 +920%
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$330K -$1.04M -161,806 -75%
MFG
38
Merit Financial Group
Georgia
$295K
Two Sigma Advisers
39
Two Sigma Advisers
New York
$268K +$287K +44,700 New
JC
40
JBF Capital
Colorado
$262K
CCIA
41
Campbell & Co Investment Adviser
Maryland
$240K -$201K -31,264 -44%
RJA
42
Raymond James & Associates
Florida
$239K +$255K +39,756 New
Osaic Holdings
43
Osaic Holdings
Arizona
$178K
Qube Research & Technologies (QRT)
44
Qube Research & Technologies (QRT)
United Kingdom
$157K -$21.1K -3,285 -11%
William Blair & Company
45
William Blair & Company
Illinois
$138K
BA
46
Bard Associates
Illinois
$126K +$642 +100 +0.5%
Geode Capital Management
47
Geode Capital Management
Massachusetts
$116K
BA
48
BCM Advisors
Louisiana
$109K
Victory Capital Management
49
Victory Capital Management
Texas
$86K +$180 +28 +0.2%
Bank of America
50
Bank of America
North Carolina
$82K -$34.6K -5,387 -28%

VMD Hedge Fund Activity: Q3 2022 in Review

65 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Viemed Healthcare (VMD) for Q3 2022, worth a combined $110M — up 5.5% from $104M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of VMD and 8 opened new positions — a net loss of 11 holders — while 23 trimmed existing stakes and 20 added.

The largest buyer was Hillsdale Investment Management, adding an estimated $4.55M. The largest seller was Forager Capital Management, exiting entirely with an estimated $8.62M sold.

  • 65 institutional investors held Viemed Healthcare (VMD) as of Q3 2022, down from 76 in Q2 2022.
  • Funds reported $110M of Viemed Healthcare stock for Q3 2022, up 5.5% quarter-over-quarter.
  • 8 funds opened new Viemed Healthcare positions in Q3 2022 and 19 closed out, a net change of -11 holders.
  • The largest Viemed Healthcare buyer in Q3 2022 was Hillsdale Investment Management, an estimated $4.55M added.
  • The largest Viemed Healthcare seller in Q3 2022 was Forager Capital Management, an estimated $8.62M sold.

Based on aggregated 13F filings for Q3 2022.